Medtech start-up Atturos is preparing to bring to market a blood test that could help men diagnosed with prostate cancer avoid undergoing unnecessary surgery. “The lead product we have in development is a test for men who have been diagnosed with low to intermediate prostate cancer,” said David Corr, chief executive of Atturos. “They have to decide whether to opt for surgery and radiotherapy or go on to an active surveillance programme. These treatment options...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team